Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)

NCT03092505 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT03092505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
June 15, 2018
Completion date
February 4, 2021
Enrollment
190 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

herpes virus-related illnesses